共 11 条
- [2] How health technology reassessment can support disinvestment in China's national drug reimbursement list BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
- [3] HOW CAN US GOVERNMENT CONTROL PHYSICIANS FEES UNDER NATIONAL HEALTH INSURANCE - LESSON FROM FRENCH SYSTEM INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1974, 4 (01): : 49 - 57
- [7] Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016 Retrospective study using the French Transparency in Healthcare and National Health Data System databases EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2020, (159): : 18 - 20
- [9] Necessity for a System Implementing Therapeutic Drug Monitoring in Outpatient Settings Based on the Actual Use of Voriconazole Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan: A Descriptive Epidemiological Study BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (10) : 1490 - 1493
- [10] Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases (vol 367, l6015, 2019) BMJ-BRITISH MEDICAL JOURNAL, 2019, 367